| EGFR gene copy number alterations in primary cutaneous malignant melanomas are associated with poor prognosis Z Rákosy, L Vízkeleti, S Ecsedi, Z Vokó, Á Bégány, M Barok, Z Krekk, ... International journal of cancer 121 (8), 1729-1737, 2007 | 115 | 2007 |
| Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy B Ács, V Zámbó, L Vízkeleti, AM Szász, L Madaras, G Szentmártoni, ... Diagnostic pathology 12, 1-12, 2017 | 102 | 2017 |
| Breast carcinoma subtypes show different patterns of metastatic behavior IA Molnár, BÁ Molnár, L Vízkeleti, K Fekete, J Tamás, P Deák, C Szundi, ... Virchows Archiv 470, 275-283, 2017 | 102 | 2017 |
| Genetic progression of malignant melanoma J Tímár, L Vizkeleti, V Doma, T Barbai, E Rásó Cancer and Metastasis Reviews 35 (1), 93-107, 2016 | 69 | 2016 |
| Characterization of candidate gene copy number alterations in the 11q13 region along with BRAF and NRAS mutations in human melanoma V Lázár, S Ecsedi, AG Szöllősi, R Tóth, L Vízkeleti, Z Rákosy, Á Bégány, ... Modern Pathology 22 (10), 1367-1378, 2009 | 62 | 2009 |
| The role of CCND1 alterations during the progression of cutaneous malignant melanoma L Vízkeleti, S Ecsedi, Z Rákosy, A Orosz, V Lázár, G Emri, V Koroknai, ... Tumor Biology 33, 2189-2199, 2012 | 58 | 2012 |
| Evaluating the significance of density, localization, and PD-1/PD-L1 immunopositivity of mononuclear cells in the clinical course of lung adenocarcinoma patients with brain … V Téglási, L Reiniger, K Fábián, O Pipek, I Csala, AG Bagó, P Várallyai, ... Neuro-oncology 19 (8), 1058-1067, 2017 | 46 | 2017 |
| Integrative genomics identifies gene signature associated with melanoma ulceration Z Rakosy, S Ecsedi, R Toth, L Vizkeleti, H Herandez-Vargas, V Lazar, ... PLoS One 8 (1), e54958, 2013 | 43 | 2013 |
| DNA hypermethylation is associated with invasive phenotype of malignant melanoma V Koroknai, I Szász, H Hernandez‐Vargas, N Fernandez‐Jimenez, ... Experimental dermatology 29 (1), 39-50, 2020 | 35 | 2020 |
| DNA methylation characteristics of primary melanomas with distinct biological behaviour S Ecsedi, H Hernandez-Vargas, SC Lima, L Vizkeleti, R Toth, V Lazar, ... PloS one 9 (5), e96612, 2014 | 34 | 2014 |
| The role of osteopontin expression in melanoma progression T Kiss, S Ecsedi, L Vizkeleti, V Koroknai, G Emri, N Kovács, R Adany, ... Tumor Biology 36, 7841-7847, 2015 | 31 | 2015 |
| Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization V Lazar, S Ecsedi, L Vízkeleti, Z Rakosy, G Boross, B Szappanos, ... Melanoma research 22 (3), 202-214, 2012 | 30 | 2012 |
| Characterization of 9p21 copy number alterations in human melanoma by fluorescence in situ hybridization Z Rákosy, L Vízkeleti, S Ecsedi, Á Bégány, G Emri, R Ádány, M Balázs Cancer genetics and cytogenetics 182 (2), 116-121, 2008 | 30 | 2008 |
| Altered integrin expression patterns shown by microarray in human cutaneous melanoma L Vizkeleti, T Kiss, V Koroknai, S Ecsedi, O Papp, I Szasz, R Adany, ... Melanoma research 27 (3), 180-188, 2017 | 26 | 2017 |
| Molecular alterations associated with acquired resistance to BRAFV600E targeted therapy in melanoma cells I Szász, V Koroknai, T Kiss, L Vízkeleti, R Ádány, M Balázs Melanoma research 29 (4), 390-400, 2019 | 25 | 2019 |
| Chromosomal imbalances are associated with increased proliferation and might contribute to bone destruction in cholesteatoma S Ecsedi, Z Rákosy, L Vízkeleti, A Juhász, I Sziklai, R Ádány, M Balázs Otolaryngology–Head and Neck Surgery 139 (5), 635-640, 2008 | 20 | 2008 |
| Genomic profiling of invasive melanoma cell lines by array comparative genomic hybridization V Koroknai, S Ecsedi, L Vízkeleti, T Kiss, I Szász, A Lukács, O Papp, ... Melanoma research 26 (2), 100-107, 2016 | 16 | 2016 |
| Combined GM-CSF treatment and M-CSF inhibition of tumor-associated macrophages induces dendritic cell-like signaling in vitro Y Kitoh, M Saio, N Gotoh, N Umemura, K Nonaka, J Bai, L Vizkeleti, ... International journal of oncology 38 (5), 1409-1419, 2011 | 15 | 2011 |
| EGFR protein expression of KRAS wild-type colorectal cancer: predictive value of the sidedness for efficacy of anti-EGFR therapy A Uhlyarik, V Piurko, L Vizkeleti, Z Pápai, E Rásó, E Lahm, E Kiss, ... Pathology & Oncology Research 26, 1429-1434, 2020 | 12 | 2020 |
| The Strong In Vivo Anti-Tumor Effect of the UIC2 Monoclonal Antibody Is the Combined Result of Pgp Inhibition and Antibody Dependent Cell-Mediated Cytotoxicity G Szalóki, ZT Krasznai, Á Tóth, L Vízkeleti, AG Szöllősi, G Trencsényi, ... PloS one 9 (9), e107875, 2014 | 12 | 2014 |
